Empowering of Oncology Patients and Informal Caregivers: Analysis of an Interdisciplinary Seminar Model for Breast Cancer and Gyneco-Oncological Patients.

IF 2 4区医学 Q3 ONCOLOGY

Oncology Research and Treatment Pub Date : 2024-01-01 Epub Date: 2024-08-12 DOI:10.1159/000539923

Hannah Hollaender, Petra Ortner, Alexander Koenig, Nicole Erickson, Kerstin Hermelink, Tom Degenhardt, Dorit Di Gioia, Sven Mahner, Nadia Harbeck, Rachel Wuerstlein

{"title":"Empowering of Oncology Patients and Informal Caregivers: Analysis of an Interdisciplinary Seminar Model for Breast Cancer and Gyneco-Oncological Patients.","authors":"Hannah Hollaender, Petra Ortner, Alexander Koenig, Nicole Erickson, Kerstin Hermelink, Tom Degenhardt, Dorit Di Gioia, Sven Mahner, Nadia Harbeck, Rachel Wuerstlein","doi":"10.1159/000539923","DOIUrl":null,"url":null,"abstract":"Introduction: The interdisciplinary empowerment seminar aims to familiarize patients and informal caregivers (ICs) with supportive measures, focusing on understanding disease, therapy, and side effect management.Methods: The seminar, conducted in two courses over 1-month intervals prior to chemotherapy, included lectures, supportive materials, Q and A sessions, and individual discussions with experts in nutrition, exercise, psycho-oncology, and complementary medicine. Evaluation is based on a self-developed questionnaire and questionnaires on QoL (EORTC-QLQ-C30, BR23, CX24, OV28), anxiety and depression (HADS-D) at week 0, 5, 9, and 12. A control group with standard of care was evaluated at baseline and after 12 weeks.Results: Between October 2020 and May 2021, 19 patients and 9 ICs participated in the seminar. The control group included 20 patients. 96.4% of participants were highly satisfied with the seminar and would recommend it. QoL deterioration was more pronounced in the control group (control: week 0 = 67.6; week 12 = 61.7; intervention: week 0 = 60.8; week 12 = 60.7). This trend could not be proven by analysis of interaction (mixed ANOVA: p = 0.114). Increased confidence of participants' knowledge about side effects was shown, and ICs reported higher confidence in knowledge and coping with the disease.Conclusions: The seminar received positive feedback and indicated increased knowledge and a trend toward better QoL preservation. Larger studies are needed for confirmation. The seminar effectively addressed unique needs, bolstering confidence and knowledge. Interdisciplinary patient and caregiver empowerment seminars can improve disease-related knowledge and positively affect QoL at the start of chemotherapy. Informational needs can be satisfied. Offering educational seminars and fostering individualized support networks can increase quality of care.","PeriodicalId":19543,"journal":{"name":"Oncology Research and Treatment","volume":" ","pages":"509-517"},"PeriodicalIF":2.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology Research and Treatment","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000539923","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/12 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: The interdisciplinary empowerment seminar aims to familiarize patients and informal caregivers (ICs) with supportive measures, focusing on understanding disease, therapy, and side effect management.

Methods: The seminar, conducted in two courses over 1-month intervals prior to chemotherapy, included lectures, supportive materials, Q and A sessions, and individual discussions with experts in nutrition, exercise, psycho-oncology, and complementary medicine. Evaluation is based on a self-developed questionnaire and questionnaires on QoL (EORTC-QLQ-C30, BR23, CX24, OV28), anxiety and depression (HADS-D) at week 0, 5, 9, and 12. A control group with standard of care was evaluated at baseline and after 12 weeks.

Results: Between October 2020 and May 2021, 19 patients and 9 ICs participated in the seminar. The control group included 20 patients. 96.4% of participants were highly satisfied with the seminar and would recommend it. QoL deterioration was more pronounced in the control group (control: week 0 = 67.6; week 12 = 61.7; intervention: week 0 = 60.8; week 12 = 60.7). This trend could not be proven by analysis of interaction (mixed ANOVA: p = 0.114). Increased confidence of participants' knowledge about side effects was shown, and ICs reported higher confidence in knowledge and coping with the disease.

Conclusions: The seminar received positive feedback and indicated increased knowledge and a trend toward better QoL preservation. Larger studies are needed for confirmation. The seminar effectively addressed unique needs, bolstering confidence and knowledge. Interdisciplinary patient and caregiver empowerment seminars can improve disease-related knowledge and positively affect QoL at the start of chemotherapy. Informational needs can be satisfied. Offering educational seminars and fostering individualized support networks can increase quality of care.

查看原文本刊更多论文

增强肿瘤患者和非正式护理人员的能力：分析针对乳腺癌和妇科肿瘤患者的跨学科研讨会模式。

简介：跨学科赋权研讨会旨在让患者和非正规护理人员（IC）熟悉支持性措施，重点是了解疾病、治疗和副作用管理。方法研讨会在化疗前分两期进行，每期间隔一个月，内容包括讲座、辅助材料、问答环节，以及与营养学、运动、肿瘤心理学和补充医学专家的单独讨论。评估基于一份自我开发的问卷，以及第 0、5、9 和 12 周的 QoL（EORTC-QLQ-C30、BR23、CX24、OV28）、焦虑和抑郁（HADS-D）问卷。对照组在基线和 12 周后接受标准护理评估。结果 2020 年 10 月至 2021 年 5 月期间，19 名患者和 9 名 IC 参与了研讨会。对照组包括 20 名患者。96.4%的参与者对研讨会非常满意，并愿意推荐参加。对照组患者的生活质量下降更为明显（对照组：W0=67.6；W12=61.7；干预组：W0=60.8；W12=60.7）。这一趋势无法通过交互分析得到证实（混合方差分析：P=0.114）。参加者对副作用知识的信心有所提高，综合症患者对疾病知识和应对疾病的信心也有所提高。结论研讨会获得了积极的反馈，显示了知识的增长和更好的 QoL 维护趋势。需要更大规模的研究来证实。研讨会有效地满足了独特的需求，增强了信心和知识。跨学科患者和护理人员赋权研讨会可在化疗开始时提高疾病相关知识，并对 QoL 产生积极影响。满足信息需求。提供教育研讨会和培养个性化的支持网络可以提高护理质量。.

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Oncology Research and Treatment ONCOLOGY-

CiteScore

3.20

自引率

0.00%

发文量

期刊介绍： With the first issue in 2014, the journal ''Onkologie'' has changed its title to ''Oncology Research and Treatment''. By this change, publisher and editor set the scene for the further development of this interdisciplinary journal. The English title makes it clear that the articles are published in English – a logical step for the journal, which is listed in all relevant international databases. For excellent manuscripts, a ''Fast Track'' was introduced: The review is carried out within 2 weeks; after acceptance the papers are published online within 14 days and immediately released as ''Editor’s Choice'' to provide the authors with maximum visibility of their results. Interesting case reports are published in the section ''Novel Insights from Clinical Practice'' which clearly highlights the scientific advances which the report presents.